Progestational adjuvant therapy

Details Progestational adjuvant therapy Progestational adjuvant therapy

A - Human Necessities

61

K

167/194

A61K 31/57 (2006.01)

Patent

CA 1205744

PROGESTATIONAL ADJUVANT THERAPY Abstract of the Disclosure Oral treatment with megestrol acetate improves survival rate and reduces the recurrence rate in the adjuvant therapy of breast cancer following mastectomy.

413579

Affiliated with

Also associated with

Rating

Progestational adjuvant therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Progestational adjuvant therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Progestational adjuvant therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1235764